4 months ago
NBIX
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 11%
#611 out of 5515 analysts
Average Return
+5%
Win Rate
46%153 out of 335
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Buy |
Contineum Therapeutics IncCTNM | +260.66% | $3.94 | $14.21 | 2025-05-15 - 2026-05-14 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
7 months ago
NBIX
a year ago
GILD
2 years ago
APLT
3 years ago
DFTX
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xenon Pharmaceuticals IncXENE | 23 | Buy | $70.00 | +76.10% | Maintains | 2 days ago |
Definium Therapeutics IncDFTX | 13 | Buy | $66.00 | +70.06% | Reiterates | 10 days ago |
Biocryst Pharmaceuticals IncBCRX | 19 | Hold | $11.00 | +26.73% | Downgrades | 10 days ago |
Evommune IncEVMN | 3 | Buy | $21.00 | +117.62% | Maintains | 12 days ago |
Neurocrine Biosciences IncNBIX | 29 | Buy | $198.00 | +35.40% | Reiterates | 12 days ago |
Attovia Therapeutics IncATTO | 1 | Buy | $45.00 | +103.25% | Initiates Coverage On | 21 days ago |
Biogen IncBIIB | 45 | Buy | $260.00 | +20.65% | Maintains | a month ago |
Pharvaris NvPHVS | 3 | Buy | $52.00 | +42.97% | Maintains | a month ago |
Lakefront Biotherapeutics NvLKFT | 14 | Hold | $26.00 | -8.93% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 3 | Buy | $36.00 | +41.51% | Maintains | a month ago |
Gilead Sciences IncGILD | 36 | Hold | $123.00 | -18.06% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 7 | Buy | $37.00 | +35.58% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 40 | Hold | $737.00 | -6.10% | Maintains | 2 months ago |
Contineum Therapeutics IncCTNM | 7 | Buy | $23.00 | +69.99% | Maintains | 2 months ago |
Incyte CorpINCY | 26 | Hold | $109.00 | -13.02% | Maintains | 2 months ago |
Neumora Therapeutics IncNMRA | 8 | Buy | $5.00 | +584.93% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 3 | Hold | $115.00 | -2.34% | Downgrades | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 59 | Buy | $570.00 | +12.13% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 23 | Hold | $85.00 | +30.03% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 6 | Hold | $135.00 | -0.05% | Maintains | 3 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $40.00 | +77.07% | Initiates Coverage On | 5 months ago |
Moonlake ImmunotherapeuticsMLTX | 5 | Hold | $13.00 | +4.92% | Maintains | 7 months ago |
Aardvark Therapeutics IncAARD | 6 | Hold | $6.00 | +11.52% | Downgrades | 7 months ago |
Prothena Corp Public Ltd CoPRTA | 13 | Hold | $12.00 | +39.86% | Maintains | 7 months ago |
Gh Research PLCGHRS | 2 | Buy | $40.00 | +41.54% | Maintains | 8 months ago |
Sionna Therapeutics IncSION | 2 | Sell | $24.00 | +302.68% | Downgrades | 10 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 9 | Buy | $53.00 | +608.56% | Maintains | 10 months ago |
Atyr Pharma IncATYR | 2 | Hold | $1.00 | +175.48% | Maintains | 10 months ago |
Pliant Therapeutics IncPLRX | 14 | Hold | $2.00 | +80.18% | Maintains | 10 months ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $145.00 | -34.50% | Maintains | 10 months ago |
Karyopharm Therapeutics IncKPTI | 12 | Buy | $19.00 | +910.64% | Maintains | a year ago |
89bio IncETNB | 14 | Hold | $11.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 31 | Hold | $23.00 | N/A | Maintains | a year ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | N/A | Reiterates | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | N/A | Reiterates | a year ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | N/A | Maintains | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | N/A | Reiterates | 2 years ago |
Intra Cellular Therapies IncITCI | 18 | Hold | $132.00 | N/A | Downgrades | 2 years ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Ataibeckley IncATAI | 3 | Hold | $9.00 | N/A | Maintains | 4 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 6 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 9 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.